| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.047 | 0.8 |